Summary
Results from a propensity-matched cohort study suggest that long-term outcomes for patients with stage I non–small cell lung cancer may be superior with surgery than with stereotactic body radiation therapy.
- stage I non–small cell lung cancer
- NSCLC
- stereotactic body radiation therapy
- stereotactic ablative radiation therapy
- SBRT
- SABR
- propensity-matched cohort study
- oncology clinical trials
- © 2015 SAGE Publications
Tools
Hints of Better Survival With Surgery Than Radiation Therapy in Stage I NSCLC
Permalink:
Table of contents
Cited By...
- No citing articles found.